FRIGOPROTECTIVE PROPERTIES OF 5,7-DIACYL-3-H(ALKYL)-6-ARYL-5H-[1,2,4]TRIAZOL[3,4-B][1,3,4]THIADIAZINE DERIVATIVES IN THE EXPERIMENT

Authors

  • A. Ya. Koval DANYLO HALYTSKY LVIV NATIONAL MEDICAL UNIVERSITY
  • S. Yu. Strygol NATIONAL UNIVERSITY OF PHARMACY, KHARKIV
  • R. B. Lesyk DANYLO HALYTSKY LVIV NATIONAL MEDICAL UNIVERSITY
  • D. V. Lytkin NATIONAL UNIVERSITY OF PHARMACY, KHARKIV
  • I. O. Lebedynets NATIONAL UNIVERSITY OF PHARMACY, KHARKIV
  • T. K. Yudkevich NATIONAL UNIVERSITY OF PHARMACY, KHARKIV

DOI:

https://doi.org/10.11603/mcch.2410-681X.2024.i3.14912

Keywords:

cold injury, experiment, 5,7-diacyl-3-H(alkyl)-6-aryl-5H-[1,2,4]triazol[3,4-b][1,3,4]thiadiazine derivatives, body temperature, hemostasis system, markers of inflammation

Abstract

Introduction. The widespread occurrence of cold injuries, along with the insufficient effectiveness of prevention and treatment of acute cold trauma, underscores the relevance of searching for new cryoprotective agents, among which anti-inflammatory drugs play a significant role.

The aim of the study - to perform research of 5,7-diacyl-3-H(alkyl)-6-aryl-5H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines (laboratory codes IFT-180, IFT-247, IFT-251) for cryoprotective properties using an acute general cooling (AGC) model.

Research Methods. The experiments were conducted on male white non-linear mice and rats. The studied compounds at a dose of 25 mg/kg and the reference drug diclofenac sodium (14 mg/kg) were administered intragastrically 60 minutes before exposing the animals to cold at -18°C. The lifespan of the mice was determined. In the in-depth study using the AGC model (2-hour exposure at -18°C), the effect of the lead compound IFT-247 at a dose of 18 mg/kg and the reference drug diclofenac sodium (7 mg/kg) on the rectal temperature of rats was examined. The impact of the mentioned compound on the hemostasis system was also assessed. In the liver, the levels of several inflammation markers were measured using species-specific kits.

Results and Discussion. It was found that compound IFT-247 exhibited potent cryoprotective properties at the level of the reference drug, statistically significantly increasing the lifespan of mice under the AGC model. IFT-247 reduced the degree of hypothermia during a two-hour exposure at -18°C (15 mg/kg). The tested compound prevented the development of disseminated intravascular coagulation (DIC) syndrome and thrombosis, reducing the levels of D-dimer and fibrinogen in the blood serum and normalizing the prolonged thrombin time to the level of diclofenac sodium. IFT-247 inhibited the development of a systemic inflammatory response: it prevented the increase in leukotriene B4 and total leukotrienes, though to a lesser extent than diclofenac; similarly to the reference drug, it significantly reduced IL-1β levels to subnormal and TNF-α levels to normal without affecting IL-6 or the decreased levels of anti-inflammatory cytokines IL-4 and IL-10, and it normalized the elevated pro- to anti-inflammatory cytokine ratio.

Conclusion. It was established that 1-(5-acetyl-3-methyl-6-phenyl-5H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine-7-yl)-ethanone exhibits promising cryoprotective properties.

References

Nagarajan, S. (2015). Update: Cold weather injuries, active and reserve components U.S. Armed Forces, July 2010-June 2015. MSMR, 22(10), 7–12. Re­trieved from https://health.mil/News/Articles/2023/11/01/Cold-Weather-Injuries.

Stjernbrandt, A., Björ, B., Andersson, M., Bur­ström, L., Liljelind, I., Nilsson, T., Lundström, R., Wahl­ström, J. (2017). Neurovascular hand symptoms in re­lation to cold exposure in northern Sweden: a population-based study. International archives of occupational and environmental health, 90(7), 587–595. DOI: 10.1007/s00420-017-1221-3.

Shakirov, B.M. (2020). Frostbite injuries and our experience treatment in the Samarkand area Uzbekistan. International journal of burns and trauma, 10(4), 156–161. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486564/

QuickStats: Death Rates Attributed to Excessive Cold or Hypothermia Among Persons Aged ≥15 Years, by Urban-Rural Status and Age Group. National Vital Statistics System, United States, 2019. (2021). Morbidity and Mortality Weekly Report, 70(7), 258–262. DOI: 10.15585/mmwr.mm7007a6.

Cold Weather Injuries, Active and Reserve Components, U.S. Armed Forces, July 2014 – June 2019. (2019). Medical Surveillance Monthly Report, 26(11), 17-27. Retrieved from https://www.health.mil/News/Articles/2019/11/01/Cold-Weather-Injuries

Fudge, J. (2016). Exercise in the Cold: Preventing and Managing Hypothermia and Frostbite Injury. Sports Health, 8(2), 133–139. DOI: 10.1177/1941738116630542

Kravets, O., Yekhalov, V., Sedinkin, V. (2022). Optimized life support in accidental general hypotermia (scientific and literature review). Emergency medicine, 18(1), 12–20 [in Ukrainian]. DOI: 10.22141/2224-0586.18.1.2022.1453.

How to avoid hypothermia: a reminder of the basic rules of behavior in the cold. (2019). [in Ukrainian]. Retrieved from https://moz.gov.ua/article/news/jak-unik­nuti-pereoholodzhennja-nagaduemo-osnovni-pravila-povedinki-u-holod

Gross, E.A., Moore, J.C. (2012). Using throm­bolytics in frostbite injury. Journal of emergencies, trauma, and shock, 5(3), 267–271 DOI: 10.4103/0974-2700.99709

Kapelka, I. G., Shtrygol’ S.Yu. (2019). The comparative research of frigoprotective properties of nonsteroidal anti-inflammatory drugs оn the model of acute general cooling. Pharmacology and Drug Toxico­logy, 13(5), 338–343 [in Ukrainian]. DOI: 10.33250/ 13.05.338.

Kapelka, I.G., Shtrygol’, S.Yu., Lesyk, R.B., Lo­zynskyi, A.V., Khomyak, S.V., Novikov V.P. (2020). The comparative research of arachidonic acid cascade inhibitors for frigoprotective activity. Pharmacology and Drug Toxicology, 14(2), 122–128. [in Ukrainian]. DOI: 10.33250/14.02.122

Kapelka, I.G., Shtrygol’, S.Yu., Koiro, O.O., Merzlikin, S.I., Kudina, O.V., Yudkevich T.K. (2021). Effect of arachidonic acid cascade inhibitors on body temperature and cognitive functions in rats in the Morris water maze after acute cold injury. Pharmazie, 76(7), 313–316. DOI: 10.1691/ph.2021.1571

Shtrygol’, S., Koiro, O., Kudina, O., Tovchiga, O., Yudkevych, T., Oklei, D. (2022). The influence of non-steroidal anti-inflammatory drugs with different mecha­nisms of action on the course of stress reaction, the functional state of kidneys, liver, and heart on the model of acute general cooling. ScienceRise: Pharmaceutical Science, 36(2). 46–55. DOI: 10.15587/2519-4852. 2022.255797

Shtrygol’, S., Koiro, O., Kudina, O., Yudkevych, T., Gorbach, T. (2022). Comparative analysis of the effect of diclofenac sodium and etoricoxib on energy metabolism in rat liver in the acute general cooling model. Med. perspekt. 27(4), 51–57. DOI: 10.26641/2307-0404.2022. 4.271171

Shtrygol, S., Tovchiga, O., Kudina, O., Koiro, O., Yudkevich, T., Gorbach, T. (2022). The effect of non-steroidal anti-inflammatory drugs with different mecha­nisms of action on the body temperature and cyclooxy­genase pathway of the arachidonic acid cascade on the model of acute general cooling (air hypothermia) in rats. Čes. slov. Farm., 71(5), 214–222. DOI: 10.5817/CSF2022-5-214

Shtrygol’, S., Taran, A., Yudkevych, T., Lytkin, D., Lebedinets, I., Chuykova, P., Koiro, O. (2023). Effects of non-steroidal anti-inflammatory agents on systemic hemostasis during the most acute period of cold injury in rats. ScienceRise: Pharmaceutical Science, 46(6), 25–30. DOI: 10.15587/2519-4852.2023.294311

Yadlovskyi, O.Ye., Koval, А.Ya., Seredynska, N.M., Bukhtiarova, T.A., Bershova, T.A., Demchenko D.A., Bobkova, L.S., Demchenko A. M. (2015). Analgesic and anti-inflammatory activity of 5,7-diacyl-3-H(alkіl)-6-aryl-5H-[1,2,4]triazol[3,4-b][1,3,4]tіadiazin derivaties. Medical and Clinical Chemistry, 17(2), 33–38. [in Ukrainian]. DOI: 10.11603/mcch.2410-681X.2015.v17.i2.4866

Yadlovskyi, O.Y., Koval’, А.Ya., Bukhtiarova, T.A., Khomenko, V.S., Omelianenko, Z.P., Bobkova, L.S., Demchenko, D.A., Demchenko, A.M. (2015). Search of new analgesic and anti-inflammatory substances among 5,7-diacyl-3-h(alkіl)-6-aryl-5H-[1,2,4]triazol[3,4-b][1,3,4]tіadiazin derivatives. Acta Medical Leopolensia, 21(4), 59-63. [in Ukrainian]. DOI: 10.11603/mcch.2410-681X. 2015.v17.i2.4866

Koval A., Lozynskyi, A., Shtrygol’, S., Lesyk R. (2022). An overview on 1,2,4-triazole and 1,3,4-thiadiazole derivatives as potential anes­thesic and anti-inflammatory agents. ScienceRise: Pharmaceutical Science, 36(2), 10–17. DOI: 10.15587/2519-4852.2022.255276

Koval, A., Shtrygol’, S. (2023). 1-(5-acetyl-3-methyl-6-phenyl-5h-[1,2,4]triazolo [3,4-b][1,3,4]thiadiazin-7-yl)-ethanone: dose-dependence of analgesic effect, lack of opioidergic mechanism of action, effect on beha­vioral reactions and acute toxicity. Acta Medica Leopo­liensia, 29(3-4), 192-203. [in Ukrainian]. DOI: 10.25040/aml2023.3-4.192

Voloshchuk, N.I., Yuhimchuk A.V. (2023). Sex peculiarities of survival of animals with acute cold injury and correction with glucosamine hydrochloride. Pharma­cology and Drug Toxicology, 17(4), 248–254. [in Ukrai­nian]. DOI: 10.33250/17.04.248.

Bondarev, Ye.V., Shtrygol’, S.Yu., Drogovoz, S.M., Shchokina, K.G. (2018). Cold injury: preclinical study of drugs with frigoprotective properties: Guidelines. [in Ukrainian]. Kharkiv: NFU, 35.

Shtrygol’, S., Taran, A., Yudkevich T. (2023). Effects of non-steroidal anti-inflammatory agents on systemic hemostasis during the most acute period of cold injury in rats. ScienceRise: Pharmaceutical Science, 46(6), 25–30. DOI: 10.15587/2519-4852.2023.294311

Kovalenko, V.M., Stefanov, O.V., Maksimov, Yu.M., Trachtenberg I.M. (2001). Experimental study of the toxic effect of potential medicinal products. In Preclinical studies of medicinal products: Guidelines. Edited by Stefanov, O.V. [in Ukrainian]. Kyiv: Avicena, 74-97.

Adelborg, K., Larsen, J.B., Hvas, A.-M. (2021) Disseminated intravascular coagulation: epidemiology, biomarkers, and management. British Journal of Haema­tology, 192, 803-818. DOI: 10.1111/bjh.17172

Yukhimchuk, A.V., Voloshchuk, N.I., Shtrygol’, S.Yu. (2023). The effect of glucosamine on the blood coagu­lation system in male and female rats with acute cold injury. In Clinical pharmacology today: ways of maximum assistance to the medical specialty: Proceedings of the XII Ukrainian scientific-and-practical; conference with participants of foreign specialists in clinical pharmacology. Vinnitsia, November, 9-10, 2023, 170-172 [in Ukrainian].

Bondarev, Ye.V. (2020). Experimental substan­tiation of optimization of cold injury prevention and treatment with the preparations targeting metabolism and inflammation. Thesis for a Doctor of Pharmaceutical Sciences Degree. National Pharmaceutical University of the Ministry of Healthcare of Ukraine, Kharkiv, 431 [in Ukrainian].

Jin Hong-Xu, Teng Yue, Dai Jing, Zhao Xiao-Dong (2021). Expert consensus on the prevention, diagnosis and treatment of cold injury in China. Military Medical Research, 8, 6. DOI: 10.1186/s40779-020-00295-z

Rathjen, N.A., Shahbodaghi, S.D., Brown J.A. (2019). Hypothermia and Cold Weather Injuries. Ame­rican Family Physician, 100 (11), 680-686. Retrieved from: https://www.aafp.org/pubs/afp/issues/2019/1201/p680.html

Mohr, J.P. (ed.) (2004). Stroke Pathophysiology, diagnosis, and management. 4th ed. New York: Churchill Livingstone, 2004. 1591. DOI: 10.1016/B0-443-06600-0/X5001-9

Yuhimchuk, A.V., Voloshchuk, N.I., Shtrygol’, S. Yu., Nefodov, O.O., Piliponova, V.V., Oliinyk,Yu.M., Tepla, A.M., Nefodova, O.O. (2023). Vascular mechanisms in the formation of gender differences in the protective effect of glucosamine in experimental cold injury. World of Medi­cine and Biology, 86(4), 243–247. DOI: 10.26724/2079-8334-2023-4-86-243-247

Kapelka, I.G.,. Strygol’, S.Yu. (2020). The charac­teristics of the anti-inflammatory action of sodium dic­lofenac in cold and normal environment. News of Phar­macy, 100(2), 106–112. [in Ukrainian]. DOI: 10.24959/nphj.20.37

Published

2024-10-23

How to Cite

Koval, A. Y., Strygol, S. Y., Lesyk, R. B., Lytkin, D. V., Lebedynets, I. O., & Yudkevich, T. K. (2024). FRIGOPROTECTIVE PROPERTIES OF 5,7-DIACYL-3-H(ALKYL)-6-ARYL-5H-[1,2,4]TRIAZOL[3,4-B][1,3,4]THIADIAZINE DERIVATIVES IN THE EXPERIMENT. Medical and Clinical Chemistry, (3), 22–32. https://doi.org/10.11603/mcch.2410-681X.2024.i3.14912

Issue

Section

ORIGINAL INVESTIGATIONS